https://www.selleckchem.com/products/ikk-16.html
t effectively predicted the prognosis of LUAD patients. CD1B expression is correlated with better prognosis and promotes antitumor immunity in LUAD, which may serve as a potential prognostic biomarker and immune-related therapeutic target for LUAD. Ventilator-associated pneumonia (VAP) is one of the most common infections in intensive care units (ICU) with a 6-52% incidence. The VAP mortality rate is 50% to 70%. Medical professionals (MPs) working in the ICU are expected to follow the guidelines to prevent VAP. The study aimed to assess